Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)
NCT03828942
·
clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Hematological Abnormality
Hematotoxicity
Interventions
DRUG:
drug inducing hematological toxicity
Sponsor
Groupe Hospitalier Pitie-Salpetriere
Collaborators
[object Object]